Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
MACROCYCLIC PEPTIDOMIMETIC PROTEASE INHIBITOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/008044
Kind Code:
A1
Abstract:
A compound, which is a compound represented by formula (I) or a stereoisomer, tautomer, nitrogen oxide, solvate, metabolite, pharmaceutically acceptable salt or prodrug thereof. The compound represented by formula (I) can significantly inhibit Mpro or inhibit coronavirus replication, and has good metabolic stability.

More Like This:
Inventors:
YU YANG (CN)
XUE DING (CN)
LIU WEI (CN)
Application Number:
PCT/CN2023/105562
Publication Date:
January 11, 2024
Filing Date:
July 03, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
TENCENT TECH SHENZHEN CO LTD (CN)
International Classes:
C07K5/027; A61K31/407; A61P31/14; C07D491/20; C07K5/097
Domestic Patent References:
WO2007001406A22007-01-04
WO2022013684A12022-01-20
Foreign References:
US20220380377A12022-12-01
CN114805478A2022-07-29
CN114426568A2022-05-03
US20220062232A12022-03-03
Other References:
OWEN DAFYDD R., ALLERTON CHARLOTTE M. N., ANDERSON ANNALIESA S., ASCHENBRENNER LISA, AVERY MELISSA, BERRITT SIMON, BORAS BRITTON, : "An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, vol. 374, no. 6575, 24 December 2021 (2021-12-24), US , pages 1586 - 1593, XP093025782, ISSN: 0036-8075, DOI: 10.1126/science.abl4784
ELIEL, EWILEN, S.: "Stereochemistry of Organic Compounds", 1994, JOHN WILEY & SONS, INC.
THOMAS SORRELL: "Organic Chemistry", 1999, UNIVERSITY SCIENCE BOOKS
MICHAEL B. SMITHJERRY MARCH: "March's Advanced Organic Chemistry", 2007, JOHN WILEY & SONS
"Dictionary of Chemical Terms", 1984, MCGRAW-HILL BOOK COMPANY
L. W. DEADY, SYN. COMM, vol. 7, 1977, pages 509 - 514
S. M. BERGE ET AL., J. PHARMACEUTICAL SCIENCES, vol. 66, 1977, pages 1 - 19
T. HIGUCHIV STELLA: "Pro-drugs as Novel Delivery Systems", A.C.S. SYMPOSIUM SERIES, vol. 14
"American Pharmaceutical Association", 1987, PERGAMON PRESS, article "Bioreversible Carriers in Drug Design"
J. RAUTIO ET AL.: "Prodrugs: Design and Clinical Applications", NATURE REVIEW DRUG DISCOVERY, vol. 7, 2008, pages 255 - 270, XP055227338, DOI: 10.1038/nrd2468
S. J. HECKER ET AL.: "Prodrugs of Phosphates and Phosphonates", JOURNAL OF MEDICINAL CHEMISTRY, vol. 51, 2008, pages 2328 - 2345, XP008148502, DOI: 10.1021/jm701260b
JACQUES ET AL.: "Enantiomers, Racemates and Resolutions", 1981, WILEY INTERSCIENCE
"Principles of Asymmetric Synthesis", 2012, ELSEVIER
ELIEL, E.L: "Stereochemistry of Carbon Compounds", 1962, MCGRAW-HILL
WILEN, S.H: "Tables of Resolving Agents and Optical Resolutions", 1972, UNIV. OF NOTRE DAME PRESS, pages: 268
"Remington's Pharmaceutical Sciences", 1985, MACK PUBLISHING COMPANY, pages: 1289 - 1329
T W. GREENE: "Protective Groups in Organic Synthesis", 1991, JOHN WILEY&SONS
P. J. KOCIENSKI, PROTECTING GROUPS, 2005
"Handbook of Pharmaceutical Salts: Properties, Selection, and Use", 2002, WILEY-VCH
"Remington: The Science and Practice of Pharmacy", 2005, LIPPINCOTT WILLIAMS & WILKINS
"Encyclopedia of Pharmaceutical Technology", 1988, MARCEL DEKKER
Attorney, Agent or Firm:
BEIJING LISENG INTELLECTUAL PROPERTY AGENCY LTD. (CN)
Download PDF: